直接经皮腔内冠状动脉介入治疗(Primary percutaneous coronary intervention,Primary PCI)是能短时间内迅速开通梗死相关血管(infarct related artery, IRA),使心肌得...
基于2个网页-相关网页
Methods From January 2005 to September 2006,164 patients with STEMI underwent primary percutaneous coronary intervention(primary PCI),who were divided into two groups.
方法对2005年1月至2006年9月164例STEMI患者行直接冠状动脉介入治疗手术(直接PCI),并将患者分为两组。
参考来源 - 应用药物洗脱支架治疗急性心肌梗死急性闭塞病变的近期临床疗效·2,447,543篇论文数据,部分数据来源于NoteExpress
The plasma BNP levels in the patients after primary PCI decrease significantly. The patients with no-PCI has higher mortality.
直接PCI治疗后血浆BNP浓度下降显著,未行PCI治疗的患者死亡率高。
The plasma BNP levels of the patients were reduced after primary PCI or delayed PCI(P<0.05), but the reduced level was higher in the patients after primary PCI(P<0.05).
直接和延迟PCI治疗后均能使血浆BNP水平较术前下降(P<0.05),但直接PCI治疗术后血浆BNP水平明显低于延迟PCI治疗术后的血浆BNP水平(P<0.05)。
Background: Pooled data from randomized controlled trials suggest that the use of abciximab may be associated with a survival advantage in patients undergoing primary PCI for acute STEMI.
背景——来自随机对照试验的汇萃数据表明,因急性ST段抬高型心肌梗塞行直接PC I术后的患者,使用阿昔单抗可以提高生存率。
应用推荐